bling health care headlines

MedImmune says contracts safe from H1N1 recall

MedImmune said its voluntary recall of about a fifth of its H1N1 vaccines, focusing on those found to be less potent over time than expected, will not affect its $453 million in contracts to supply the product to federal agencies to be distributed.
Source: Atlanta Business Chronicle